Triathlon Medical Venture Partners, a Midwest-based venture capital firm, finances life sciences companies.
Business Model:
Revenue: $6.6M
Employees: 2-10
Address: P O Box 42862
City: Cincinnati
State: OH
Zip: 45242
Country: US
Triathlon Medical Venture Partners is a venture capital company that offers private equity investment services to firms in the biopharmaceutical and medical device industries. It was founded in 2004 by Dennis Costello and John Rice and is based in Ohio.
Contact Phone:
+15135706238
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
5/2012 | Mitralign | Series D | 0 |
1/2011 | Celleration | Series E | 0 |
4/2014 | Aerpio Pharmaceuticals | Series C | 0 |
3/2017 | Aerpio Pharmaceuticals | Venture Round | 0 |
12/2007 | Mitralign | Series C | 0 |
3/2007 | Endocyte | Series C | 15M |
7/2012 | Juventas Therapeutics | Series B | 0 |
11/2006 | Endocyte | Venture Round | 30M |
9/2005 | Kereos | Series B | 0 |
1/2008 | Hydrocision | Series H | 4.8M |
3/2005 | Renal Solutions | Series B | 16.5M |
1/2005 | Remon Medical Technologies | Series C | 0 |
11/2013 | Aerpio Pharmaceuticals | Series A | 0 |
3/2009 | BioVex | Venture Round | 40M |
4/2006 | Mitralign | Series B | 3.3M |
6/2010 | Tolera Therapeutics | Series B | 4.1M |
6/2007 | Alluxa | Venture Round | 1.5M |
1/2007 | Hydrocision | Series G | 12.7M |
6/2008 | Tolera Therapeutics | Series A | - |
4/2014 | Alluxa | Venture Round | 0 |
6/2013 | Akebia Therapeutics | Series C | 0 |
10/2008 | Juventas Therapeutics | Series A | 7.7M |
10/2012 | Tolera Therapeutics | Series B | 0 |
11/2007 | BioVex | Series E | 35M |
4/2011 | Akebia Therapeutics | Series B | 0 |
1/2008 | CS-Keys | Series A | 6.3M |
1/2006 | CoLucid Pharmaceuticals | Series A | 0 |
1/2015 | CoLucid Pharmaceuticals | Series C | 0 |
8/2011 | CoLucid Pharmaceuticals | Venture Round | 0 |
7/2008 | CoLucid Pharmaceuticals | Series B | 0 |
12/2006 | Hydrocision | Series G | 12.7M |
1/2010 | Endocyte | Series C | 26M |
7/2008 | Celleration | Series D | 0 |
7/2009 | Akebia Therapeutics | Series A | 25M |
6/2006 | Mitralign | Series B | 13M |
3/2017 | Aerpio Pharmaceuticals | Venture Round | 0 |
1/2015 | CoLucid Pharmaceuticals | Series C | 0 |
4/2014 | Aerpio Pharmaceuticals | Series C | 0 |
4/2014 | Alluxa | Venture Round | 0 |
11/2013 | Aerpio Pharmaceuticals | Series A | 0 |
6/2013 | Akebia Therapeutics | Series C | 0 |
10/2012 | Tolera Therapeutics | Series B | 0 |
7/2012 | Juventas Therapeutics | Series B | 0 |
5/2012 | Mitralign | Series D | 0 |
8/2011 | CoLucid Pharmaceuticals | Venture Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|